Amoxapine
- TRADE NAMES: Amoxan; Amoxapine (Watson); Asendis; Defanyl; Demolox
- INDICATIONS: Depression
- CLASS: Antidepressant; tricyclic, Muscarinic antagonist
- HALF-LIFE: 11–30 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amprenavir, Artemether/Lumefantrine, Clonidine, Dronedarone, Epinephrine, Fluoxetine, Guanethidine, Iobenguane, Isocarboxazid, Linezolid, MAO inhibitors, Nilotinib, Phenelzine, Pimozide, Quetiapine, Quinine, Quinolones, Sparfloxacin, Tetrabenazine, Thioridazine, Toremifene, Tranylcypromine, Vandetanib, Vemurafenib, Ziprasidone
PREGNANCY CATEGORY: C
SUICIDALITY AND ANTIDEPRESSANT DRUGS
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric